SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-005378
Filing Date
2019-01-09
Accepted
2019-01-09 16:32:20
Documents
67
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q d683024d10q.htm 10-Q 611354
2 EX-31.1 d683024dex311.htm EX-31.1 10865
3 EX-31.2 d683024dex312.htm EX-31.2 10857
4 EX-32.1 d683024dex321.htm EX-32.1 4205
5 EX-32.2 d683024dex322.htm EX-32.2 4183
  Complete submission text file 0001193125-19-005378.txt   5370010

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cydy-20181130.xml EX-101.INS 779365
7 XBRL TAXONOMY EXTENSION SCHEMA cydy-20181130.xsd EX-101.SCH 76923
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20181130_cal.xml EX-101.CAL 50415
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20181130_def.xml EX-101.DEF 451002
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20181130_lab.xml EX-101.LAB 567368
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20181130_pre.xml EX-101.PRE 515556
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 19518511
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1